Gareth Jones

The Hospital-at-Home market has received much attention in the wake of the COVID-19 Pandemic as a means to alleviate hospital bed shortages, reduce costs, and improve health outcomes for appropriate patients. Advances in remote patient monitoring technologies and a supportive policy environment offer much promise, but formidable obstacles remain.

While the spotlight in 2023 shone on developments around Generative Artificial Intelligence (AI), away from the limelight a quiet revolution in AI was taking place, which promises to transform the way we diagnose, manage, and treat cardiovascular diseases, the world’s leading cause of death. Signify Research has just released a deep-dive qualitative analysis of developments around the use of AI to analyse and interpret electrocardiograms (ECGs), one of the world’s most ubiquitous diagnostic tests for cardiac disease.

As summer turns to Autumn in the Northern Hemisphere, healthcare practitioners, policymakers, and technology vendors have returned in large numbers to a slew of industry conferences to keep abreast of the continual developments taking place in healthcare.

Huma, a UK-based Remote Patient Monitoring (RPM) platform provider, recently announced its acquisition of iPLATO Healthcare, a major supplier of patient engagement software to primary care organisations throughout the UK.